Haverford Trust Company Upped Cvs Health Corporation (CVS) Position by $19.25 Million as Market Valuation Rose

September 30, 2018 - By Palma Niemeyer

CVS Health Corporation (NYSE:CVS) LogoInvestors sentiment increased to 1.07 in Q2 2018. Its up 0.17, from 0.9 in 2018Q1. It improved, as 65 investors sold CVS shares while 477 reduced holdings. 119 funds opened positions while 459 raised stakes. 816.99 million shares or 0.49% less from 821.03 million shares in 2018Q1 were reported. Farr Miller Washington Limited Liability Dc reported 556,066 shares or 3.24% of all its holdings. Assets Inv Management Limited Liability reported 0.29% stake. California-based Halbert Hargrove Russell Lc has invested 0.05% in CVS Health Corporation (NYSE:CVS). Garland Capital Management reported 60,290 shares. Kcm Invest Advsrs Limited Liability Company has 0.1% invested in CVS Health Corporation (NYSE:CVS). Alpine Woods Investors Lc holds 0.4% or 28,506 shares. M&R Management, a New York-based fund reported 64,054 shares. 10,447 are owned by Motley Fool Asset Mgmt Ltd Limited Liability Company. Wesbanco Commercial Bank invested in 0.18% or 53,947 shares. Westpac Bk Corp reported 66,195 shares stake. Peapack Gladstone Fincl Corp owns 149,784 shares for 0.5% of their portfolio. Pggm Invests accumulated 1.61M shares or 0.57% of the stock. Chevy Chase reported 1.31 million shares stake. Eastern Natl Bank has invested 0.91% in CVS Health Corporation (NYSE:CVS). Private Advsrs owns 8,450 shares or 0.17% of their US portfolio.

Since May 4, 2018, it had 2 insider purchases, and 2 sales for $462,391 activity. DORMAN DAVID W also bought $1.51 million worth of CVS Health Corporation (NYSE:CVS) shares. Boratto Eva C also sold $1.03 million worth of CVS Health Corporation (NYSE:CVS) shares. Hourican Kevin also sold $642,300 worth of CVS Health Corporation (NYSE:CVS) on Monday, August 27.

Haverford Trust Company increased its stake in Cvs Health Corporation (CVS) by 29.2% based on its latest 2018Q2 regulatory filing with the SEC. Haverford Trust Company bought 300,852 shares as the company’s stock rose 13.02% with the market. The institutional investor held 1.33 million shares of the medical and nursing services company at the end of 2018Q2, valued at $85.66M, up from 1.03M at the end of the previous reported quarter. Haverford Trust Company who had been investing in Cvs Health Corporation for a number of months, seems to be bullish on the $80.14B market cap company. The stock decreased 0.05% or $0.04 during the last trading session, reaching $78.72. About 6.32M shares traded. CVS Health Corporation (NYSE:CVS) has declined 6.20% since September 30, 2017 and is downtrending. It has underperformed by 21.82% the S&P500.

Haverford Trust Company, which manages about $5.06 billion US Long portfolio, decreased its stake in American Electric Power (NYSE:AEP) by 81,134 shares to 149,760 shares, valued at $10.37M in 2018Q2, according to the filing. It also reduced its holding in J.P. Morgan Chase & Co (NYSE:JPM) by 38,116 shares in the quarter, leaving it with 1.36 million shares, and cut its stake in Mastercard (NYSE:MA).

Another recent and important CVS Health Corporation (NYSE:CVS) news was published by Fool.com which published an article titled: “Why CVS Health Corporation Stock Rose 16% in August” on September 06, 2018.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 6 analysts covering CVS Health (NYSE:CVS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CVS Health had 7 analyst reports since April 11, 2018 according to SRatingsIntel. Oppenheimer maintained the stock with “Buy” rating in Wednesday, May 2 report. Bank of America maintained the shares of CVS in report on Monday, September 17 with “Buy” rating. The rating was maintained by Morgan Stanley on Tuesday, July 3 with “Overweight”. SunTrust maintained the shares of CVS in report on Tuesday, April 17 with “Buy” rating. The rating was maintained by Bank of America with “Buy” on Wednesday, April 11. The firm earned “Buy” rating on Tuesday, April 10 by Leerink Swann. Citigroup reinitiated the stock with “Buy” rating in Monday, July 9 report.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: